HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Notice of meeting Amended
Standing Committee on Health (HESA)
43rd Parliament, 2nd Session
Meeting 41
Friday, June 4, 2021, 1:00 p.m. to 4:00 p.m.Amended
Webcast
Witnesses
1:00 p.m. to 2:30 p.m.Amended
As an individual
Dr. Steven Morgan, Professor, School of Population and Public Health, University of British Columbia
BioQuébec
Anie Perrault, Chief Executive Officer
Paul Levesque, President and Chief Executive Officer, Theratechnologies Inc.
Breast Cancer Action Quebec
Sharon Batt, Co-Founder, Adjunct, Dalhousie University, Department of Bioethics
Jennifer Beeman, Executive Director
Cystic Fibrosis Canada
Kelly Grover, Chief Executive Officer
2:30 p.m. to 4:00 p.m.Amended
Innovative Medicines Canada
Pamela Fralick, President
Declan Hamill, Vice-President, Legal, Regulatory Affairs and Compliance
Institute of Health Economics
Dr. Christopher McCabe, Chief Executive Officer and Executive Director
Liv-A-Little Foundation
Erin Little, President
Clerk of the Committee
Jean-François Pagé (613-995-4108)
2021-06-03 5:17 p.m.